PL439274A1 - Method of modifying arsenic concentration in the blood with vitamin C supplementation - Google Patents

Method of modifying arsenic concentration in the blood with vitamin C supplementation

Info

Publication number
PL439274A1
PL439274A1 PL439274A PL43927421A PL439274A1 PL 439274 A1 PL439274 A1 PL 439274A1 PL 439274 A PL439274 A PL 439274A PL 43927421 A PL43927421 A PL 43927421A PL 439274 A1 PL439274 A1 PL 439274A1
Authority
PL
Poland
Prior art keywords
vitamin
supplementation
blood
modifying
arsenic concentration
Prior art date
Application number
PL439274A
Other languages
Polish (pl)
Inventor
Jan LUBIŃSKI
Dominika Mocarz
Karolina Woronko
Laura Frąckowiak
Krzysztof Lubiński
Marta Bryśkiewicz
Wojciech MARCINIAK
Róża Derkacz
Tadeusz Dębniak
Cezary Cybulski
Jacek Gronwald
Tomasz Huzarski
Original Assignee
Read-Gene Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Read-Gene Spółka Akcyjna filed Critical Read-Gene Spółka Akcyjna
Priority to PL439274A priority Critical patent/PL439274A1/en
Publication of PL439274A1 publication Critical patent/PL439274A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób obniżania poziomu arsenu we krwi charakteryzuje się tym, że obejmuje suplementację witaminą C w dawce 1 g/dzień.The subject matter of the application is a method of lowering the level of arsenic in the blood characterized in that it comprises supplementation with vitamin C at a dose of 1 g/day.

PL439274A 2021-10-21 2021-10-21 Method of modifying arsenic concentration in the blood with vitamin C supplementation PL439274A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL439274A PL439274A1 (en) 2021-10-21 2021-10-21 Method of modifying arsenic concentration in the blood with vitamin C supplementation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL439274A PL439274A1 (en) 2021-10-21 2021-10-21 Method of modifying arsenic concentration in the blood with vitamin C supplementation

Publications (1)

Publication Number Publication Date
PL439274A1 true PL439274A1 (en) 2023-04-24

Family

ID=86184097

Family Applications (1)

Application Number Title Priority Date Filing Date
PL439274A PL439274A1 (en) 2021-10-21 2021-10-21 Method of modifying arsenic concentration in the blood with vitamin C supplementation

Country Status (1)

Country Link
PL (1) PL439274A1 (en)

Similar Documents

Publication Publication Date Title
MX2021006681A (en) Anti-claudin antibodies and uses thereof.
BRPI0519265A2 (en) compositions including iron
EA202190248A1 (en) DIMERIC IMMUNOMODULATING COMPOUNDS AGAINST MECHANISMS BASED ON CEREBLON
PH12019502886A1 (en) Methods for increasing growth of beneficial bacteria in the gastrointestinal tract
MX394496B (en) Administration of Berberine Metabolites
EA201892190A1 (en) TREATMENT OF PSORIASIS WITH ANTI-BODY TO IL-12 AND / OR IL-23 WITH THE GROWTH OF THE INTERVAL BETWEEN THE INTRODUCTION OF DOSE
EA202190073A1 (en) COMPOSITIONS AND METHODS FOR TREATING TYPES OF HEMOGLOBINOPATHY AND THALASSEMIA
EA201892189A1 (en) METHODS OF TREATMENT WITH VITAMIN D
CO2022014499A2 (en) nlrp3 modulators
AU2018282105A1 (en) Dosing of vibegron for treatment of overactive bladder
EA201991570A1 (en) AMIDIC COMPOUNDS AND THEIR APPLICATION
MX2018015388A (en) Compositions for biological systems and methods for preparing and using the same.
SG11201901617PA (en) Azole compound ophthalmic preparation
MX382374B (en) CHILDREN'S NUTRITION THAT PROVIDES METABOLIC BENEFITS.
PL420267A1 (en) Polyporoid mushroom extract, a composition containing this extract and its use
EA202090728A1 (en) APPLICATION OF NOR-URSODEOXYCHOLIC ACID TO REDUCE LIVER FAT
BR112022007020A2 (en) COMPOSITION AND METHOD FOR TREATMENT OF DIABETES
UA112621U (en) METHOD OF CORRECTION OF ENDOTHELY DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES
UA120108U (en) METHOD OF TREATMENT OF CHRONIC DIFFUSIVE CATARAL GINGUITIS IN CHILDREN
Rizk Various toxicities: case report
PL422316A1 (en) Method for obtaining monoclonal antibody, the monoclonal antibody, cell CHO DG44, which co-expressions the monoclonal antibody and the composition that contains it
PL439315A1 (en) The method of determining the risk of cancer in women depending on the concentration of selenium in the blood
UA126148U (en) METHOD OF TREATMENT OF PERIAMPLANT MUCOSITE
EA202191907A1 (en) APPLICATION OF VIBEGRON FOR TREATMENT OF HYPERACTIVE BLADDER
UA144809U (en) HEPATOPROTECTORAL AGENT